Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Feprazone (DA-2370) possesses anti-inflammatory and antiadipogenic properties. Feprazone can be used in studies about the treatment of joint and muscular pain.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
5 mg | In stock | $ 40.00 | |
10 mg | In stock | $ 57.00 | |
25 mg | In stock | $ 93.00 | |
50 mg | In stock | $ 137.00 | |
100 mg | In stock | $ 197.00 | |
1 mL * 10 mM (in DMSO) | In stock | $ 39.00 |
Description | Feprazone (DA-2370) possesses anti-inflammatory and antiadipogenic properties. Feprazone can be used in studies about the treatment of joint and muscular pain. |
In vitro | Lipid accumulation, elevated production of triglycerides, the release of glycerol, upregulated SREBP-1C, FABP4, PPAR-γ, and C/EBP-α and downregulated ATGL and AQP-7 in the 3 T3-L1 adipocytes induced by the adipocyte differentiation cocktail medium were significantly reversed by treatment with Feprazone(30 and 60 μM)[1]. |
Synonyms | Prenazone, DA 2370, DA2370, DA-2370 |
Molecular Weight | 320.39 |
Formula | C20H20N2O2 |
CAS No. | 30748-29-9 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 27.5 mg/mL (85.83 mM)
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Feprazone 30748-29-9 Others Prenazone DA 2370 DA2370 DA-2370 inhibitor inhibit